Showing results (181-190 of 284) with videos related to

Sort By:
Pageof 29
Journal of the American Society of Nephrology : JASN|April 11, 2008
Impact of activated vitamin D and race on survival among hemodialysis patientsMyles Wolf, Joseph Betancourt, Yuchiao Chang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 1, 2017
Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing RisksJesse Yenchih Hsu, Jason A Roy, Dawei Xie, et al.
Kidney International|March 1, 2016
Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgeryDavid E Leaf, Marta Christov, Harald Jüppner, et al.
Circulation|May 6, 2009
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney diseaseOrlando M Gutiérrez, James L Januzzi, Tamara Isakova, et al.
Cytokine|January 8, 2017
Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritisAline L Resende, Rosilene M Elias, Myles Wolf, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 22, 2025
Nephrotic syndrome in mice elevates FGF23 levels and leads to cardiac hypertrophy in the absence of hyperphosphatemiaAbul Fajol, Qing Li, S Madison Thomas, et al.
Kidney International|August 2, 2021
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney diseaseRupal C Mehta, Monique E Cho, Xuan Cai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 15, 2017
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseMichel Chonchol, Berenice Gitomer, Tamara Isakova, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 22, 2017
Klotho, an antiaging molecule, attenuates oxidant-induced alveolar epithelial cell mtDNA damage and apoptosisSeok-Jo Kim, Paul Cheresh, Mesut Eren, et al.
British Journal of Pharmacology|June 20, 2020
Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxisJoan Perelló, Miquel D Ferrer, Maria Del Mar Pérez, et al.
Pageof 29